KOD241220P17500
- 8.30
- 0.000.00%
Kodiak Sciences Newsroom
KOD Stock Up as Jefferies Upgrades Rating on Huge Pipeline Potential
Nona Biosciences and Kodiak Sciences Partner on Next-Generation Antibody Therapies for Ophthalmic Diseases
12 Health Care Stocks Moving In Monday's Pre-Market Session
Sector Update: Health Care Stocks Edge Higher Monday Afternoon
Top Midday Gainers
Eye-Disease Focused Kodiak Sciences Is A Promising 'Turnaround Story For 2025': Analyst Upgrades Stock
Kodiak Sciences Shares Soar After Upgrade From Jefferies
Jefferies Upgrades Kodiak Sciences(KOD.US) to Buy Rating, Raises Target Price to $20
Kodiak Sciences Inc. (KOD) Just Flashed Golden Cross Signal: Do You Buy?
Kodiak Q3 Loss Narrower Than Expected, Pipeline Development in Focus
Cautious Approach: Kodiak Sciences' Retinal Pipeline Progress and Hold Rating
Express News | HC Wainwright & Co. Reiterates Neutral on Kodiak Sciences, Maintains $3 Price Target
Kodiak Sciences Analyst Ratings
Barclays Maintains Kodiak Sciences(KOD.US) With Sell Rating, Raises Target Price to $4
Barclays Remains a Sell on Kodiak Sciences (KOD)
Kodiak Sciences | 10-Q: Q3 2024 Earnings Report
Kodiak Sciences | 8-K: Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2024 Financial Results
Kodiak Sciences Reports Q3 EPS (84c), Consensus (90c)
Earnings Flash (KOD) KODIAK SCIENCES Reports Q3 Loss $-0.84
Express News | Kodiak Sciences Inc: Current Cash Will Support Our Current and Planned Operations Into 2026